Study of the Effects of Education on Patients With Chronic Obstructive Pulmonary Disease
NCT ID: NCT01633697
Last Updated: 2020-11-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
42 participants
INTERVENTIONAL
2012-09-30
2016-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators plan to enroll 42 patients into this study, with half of them participating at each of the two sites, Vermont Lung Center at the University of Vermont in Burlington, Vermont, and at Baylor College of Medicine in Houston, Texas. Participants will undergo a series of measurements and tests at the beginning of the study, receive formal education about COPD over the next 2 weeks, return at 6 weeks for a brief refresher session, and finally return after 12 weeks for repeat measurement and testing as was done at the beginning. Participants will be asked to keep a diary of symptoms, medication, and exercise during the study.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Education-Pranayama
Subjects will receive education about COPD with special attention to breathing techniques
Pranayama
Specific yoga-related breathing method.
Education-Control
Subjects will receive education alone about COPD.
Education alone
No special attention to breathing
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pranayama
Specific yoga-related breathing method.
Education alone
No special attention to breathing
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* COPD defined according to GOLD criteria, with FEV1/FVC \< 0.7, and FEV1 \< 80% predicted.
* Current non-smoker
* Stable medical regimen for COPD over last 4 weeks
* Stable physical activity over the last 4 weeks, with no plans for any change during the duration of the study
* MRC Dyspnea Scale \> 2
* Not planning to engage in any formal pulmonary rehabilitation program during the time of the study
* No use of any nutritional supplements other than standard multivitamins
Exclusion Criteria
* Concomitant other respiratory disease or significant cardiovascular disease
* Previous practice of yoga
* Current use of antioxidant supplements (e.g., vitamin C, vitamin E, n-acetylcysteine)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Heart, Lung, and Blood Institute (NHLBI)
NIH
University of Vermont
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
David Kaminsky, MD
Associate Professor of Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David Kaminsky, MD
Role: PRINCIPAL_INVESTIGATOR
University of Vermont
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Baylor College of Medicine
Houston, Texas, United States
Vermont Lung Center
Colchester, Vermont, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Vermont Lung Center
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
M12-131
Identifier Type: -
Identifier Source: org_study_id